0 Hospital plumbing as a reservoir for resistance – an interview with Amy Mathers
In this interview we speak to Amy Mathers about her research on the role of hospital plumbing in the evolution and exchange of genes of drug resistance.
Browsing: Research > Clinical
0 Gut microbiota discovered as the most common origins of hospital-acquired bloodstream infections
Researchers at Stanford University School of Medicine have reported that the most common origin of bloodstream infections, during a hospital stay, as a consequence of the patient’s own gut.
0 Bacteriophages: new method of genetic transduction uncovered
Scientists, led by the National University of Singapore and the University of Glasgow, have used the term ‘lateral transduction’ to describe a novel, dangerously-potent mechanism of bacteriophage-induced genetic transduction.
0 Infographic: Healthcare-associated infections in European hospitals
In this infographic we take a look at the estimated burden of healthcare-associated infections in acute care hospitals across Europe.
0 Pioneering CJD treatment to be tested in patient for the first time
A pioneering treatment, an antibody termed PRN100, is to be given to a patient with sporadic Creutzfeldt-Jakob disease for the first time.
0 Device-related infections, an increasing problem? – an interview with Trisha Peel
In this interview with Trisha Peel from Monash University, she explains the issues surrounding device-related infections in addition to discussing some promising new approaches to diagnosis and treatment.
0 The RESTORE-1 trial, results and real world repercussions – an interview with Keith Kaye
In this interview, we speak to to Keith Kaye, Principle Investigator of the RESTORE-1 trial assessing relebactam in combination with imipenem (IMI/REL), about the trial’s results and the implications these have for clinicians in ‘real world’ settings.
0 IDWeek: Nearly half of outpatient antibiotic prescriptions written without infection diagnosis
Nearly half of prescriptions for antibiotics were written without an infection-related diagnosis, according to a study of 509,534 prescriptions reported at IDWeek today.
0 IDWeek: Opioid-using youth could miss out on hepatitis C screening and treatment
During the current opioid crisis, only one-third of youths diagnosed with opioid use disorder were tested for hepatitis C, according to the results of a large national sample presented at IDWeek.
0 Paratek’s antibiotic Nuzyra™ (omadacycline) gains FDA approval
The US FDA has approved Paratek Pharmaceuticals’ antibiotic Nuzyra™ (omadacycline) for the treatments of adults with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
